Cargando…
Delayed revascularization in acute ischemic stroke patients
Stroke shares a significant burden of global mortality and disability. A significant decline in the quality of life is attributed to the so-called post-stroke cognitive impairment including mild to severe cognitive alterations, dementia, and functional disability. Currently, only two clinical interv...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9945110/ https://www.ncbi.nlm.nih.gov/pubmed/36843940 http://dx.doi.org/10.3389/fphar.2023.1124263 |
_version_ | 1784892068670210048 |
---|---|
author | Eastin, T. Marc Dye, Justin A. Pillai, Promod Lopez-Gonzalez, Miguel A. Huang, Lei Zhang, John H. Boling, Warren W. |
author_facet | Eastin, T. Marc Dye, Justin A. Pillai, Promod Lopez-Gonzalez, Miguel A. Huang, Lei Zhang, John H. Boling, Warren W. |
author_sort | Eastin, T. Marc |
collection | PubMed |
description | Stroke shares a significant burden of global mortality and disability. A significant decline in the quality of life is attributed to the so-called post-stroke cognitive impairment including mild to severe cognitive alterations, dementia, and functional disability. Currently, only two clinical interventions including pharmacological and mechanical thrombolysis are advised for successful revascularization of the occluded vessel. However, their therapeutic effect is limited to the acute phase of stroke onset only. This often results in the exclusion of a significant number of patients who are unable to reach within the therapeutic window. Advances in neuroimaging technologies have allowed better assessment of salvageable penumbra and occluded vessel status. Improvement in diagnostic tools and the advent of intravascular interventional devices such as stent retrievers have expanded the potential revascularization window. Clinical studies have demonstrated positive outcomes of delayed revascularization beyond the recommended therapeutic window. This review will discuss the current understanding of ischemic stroke, the latest revascularization doctrine, and evidence from clinical studies regarding effective delayed revascularization in ischemic stroke. |
format | Online Article Text |
id | pubmed-9945110 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-99451102023-02-23 Delayed revascularization in acute ischemic stroke patients Eastin, T. Marc Dye, Justin A. Pillai, Promod Lopez-Gonzalez, Miguel A. Huang, Lei Zhang, John H. Boling, Warren W. Front Pharmacol Pharmacology Stroke shares a significant burden of global mortality and disability. A significant decline in the quality of life is attributed to the so-called post-stroke cognitive impairment including mild to severe cognitive alterations, dementia, and functional disability. Currently, only two clinical interventions including pharmacological and mechanical thrombolysis are advised for successful revascularization of the occluded vessel. However, their therapeutic effect is limited to the acute phase of stroke onset only. This often results in the exclusion of a significant number of patients who are unable to reach within the therapeutic window. Advances in neuroimaging technologies have allowed better assessment of salvageable penumbra and occluded vessel status. Improvement in diagnostic tools and the advent of intravascular interventional devices such as stent retrievers have expanded the potential revascularization window. Clinical studies have demonstrated positive outcomes of delayed revascularization beyond the recommended therapeutic window. This review will discuss the current understanding of ischemic stroke, the latest revascularization doctrine, and evidence from clinical studies regarding effective delayed revascularization in ischemic stroke. Frontiers Media S.A. 2023-02-08 /pmc/articles/PMC9945110/ /pubmed/36843940 http://dx.doi.org/10.3389/fphar.2023.1124263 Text en Copyright © 2023 Eastin, Dye, Pillai, Lopez-Gonzalez, Huang, Zhang and Boling. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Pharmacology Eastin, T. Marc Dye, Justin A. Pillai, Promod Lopez-Gonzalez, Miguel A. Huang, Lei Zhang, John H. Boling, Warren W. Delayed revascularization in acute ischemic stroke patients |
title | Delayed revascularization in acute ischemic stroke patients |
title_full | Delayed revascularization in acute ischemic stroke patients |
title_fullStr | Delayed revascularization in acute ischemic stroke patients |
title_full_unstemmed | Delayed revascularization in acute ischemic stroke patients |
title_short | Delayed revascularization in acute ischemic stroke patients |
title_sort | delayed revascularization in acute ischemic stroke patients |
topic | Pharmacology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9945110/ https://www.ncbi.nlm.nih.gov/pubmed/36843940 http://dx.doi.org/10.3389/fphar.2023.1124263 |
work_keys_str_mv | AT eastintmarc delayedrevascularizationinacuteischemicstrokepatients AT dyejustina delayedrevascularizationinacuteischemicstrokepatients AT pillaipromod delayedrevascularizationinacuteischemicstrokepatients AT lopezgonzalezmiguela delayedrevascularizationinacuteischemicstrokepatients AT huanglei delayedrevascularizationinacuteischemicstrokepatients AT zhangjohnh delayedrevascularizationinacuteischemicstrokepatients AT bolingwarrenw delayedrevascularizationinacuteischemicstrokepatients |